Periumbilical vibration during IUD insertion
Official title: Effect of Periumbilical Vibration on Pain Perception During Intrauterine Device Insertion: A Randomized Controlled Trial
Run by Duke University · NCT07714590 · Data updated 2026-11-12
This study tests whether placing a vibrating device at the belly button during IUD insertion reduces the amount of pain patients feel compared with standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 114 (estimated) |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Status | Recruiting |
| Started | October 9, 2026 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07714590 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older scheduled for IUD insertion at Duke University clinics who are English-speaking and able to consent.
✕Probably not a fit
Individuals who do not experience pain reduction from vibration or have contraindications to the procedure may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compares pain during intrauterine device placement with and without a vibrating device applied to the umbilicus. Participants are assigned to receive the vibration or standard care and can use usual pain control methods. Pain is measured on a 1-100 scale at several points during the procedure, starting before the insertion. All procedures occur at Duke University, with English-speaking adults 18 and older eligible if scheduled for IUD insertion.
Why it matters
Potential benefit: If successful, the vibrating device could provide additional, nonpharmacologic pain relief during IUD insertion.
How similar studies have gone: Prior similar approaches have shown mixed results; this trial adds targeted, site-specific vibration to standard care for IUD insertion.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Capable of providing informed consent * Scheduled for IUD insertion at either Duke 1J gynecology clinic or Family Planning clinic * English-speaking Exclusion Criteria: * Currently pregnant * Planned use of IV sedation during IUD placement * Inability to provide informed consent due to disability or language barrier
Where it's running
-
Duke University Hospital
Durham, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Beverly Gray, MD — Duke Health
- Study coordinator: Madeline Thornton, MD, MPH
- Email: madeline.thornton@duke.edu
- Phone: (919) 668- 2591
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving Medication Adherence for Recently Diagnosed Cancer Patients
This pilot tests whether a pharmacist-led program plus the Medisafe app helps people with newly diagnosed cancer who take multiple medicines stick to their treatment plans.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
-
FlexED: A digital program to help young women see thoughts and feelings about their body in a friendlier way
This trial tests a smartphone-based, gamified ACT-inspired program called FlexED to help young women and girls at risk for eating disorders see how they think and feel about their bodies, and to see if it can be feasibly spread to more people.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Lupus Nephritis Care Pathway
A small group of adults with lupus nephritis will try a team-based care path that uses telemedicine and pharmacist-led support to help manage their treatment and see if it improves adherence and outcomes.
-
Temporal Interference Brain Stimulation for adults with drug-resistant focal epilepsy during stereo-EEG monitoring
This study tests whether a non-invasive Temporal Interference brain stimulation can reduce abnormal brain activity in adults with drug-resistant focal epilepsy who are undergoing stereo-EEG monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.